157 related articles for article (PubMed ID: 10437696)
1. Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases.
Traill ZC; Talbot D; Golding S; Gleeson FV
Clin Radiol; 1999 Jul; 54(7):448-51. PubMed ID: 10437696
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: a comparative study.
Yilmaz MH; Ozguroglu M; Mert D; Turna H; Demir G; Adaletli I; Ulus S; Halac M; Kanberoğlu K
Med Oncol; 2008; 25(3):257-63. PubMed ID: 18040900
[TBL] [Abstract][Full Text] [Related]
3. Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone scintigraphy in patients with breast cancer.
Altehoefer C; Ghanem N; Högerle S; Moser E; Langer M
Eur J Radiol; 2001 Oct; 40(1):16-23. PubMed ID: 11673003
[TBL] [Abstract][Full Text] [Related]
4. Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastatic solid tumors of the axial skeleton.
Ghanem N; Altehoefer C; Högerle S; Schäfer O; Winterer J; Moser E; Langer M
Eur J Radiol; 2002 Sep; 43(3):256-61. PubMed ID: 12204408
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma.
Gutzeit A; Doert A; Froehlich JM; Eckhardt BP; Meili A; Scherr P; Schmid DT; Graf N; von Weymarn CA; Willemse EM; Binkert CA
Skeletal Radiol; 2010 Apr; 39(4):333-43. PubMed ID: 20205350
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.
Lecouvet FE; Geukens D; Stainier A; Jamar F; Jamart J; d'Othée BJ; Therasse P; Vande Berg B; Tombal B
J Clin Oncol; 2007 Aug; 25(22):3281-7. PubMed ID: 17664475
[TBL] [Abstract][Full Text] [Related]
8. [Metastatic bone disease. Strategies for imaging].
Scutellari PN; Antinolfi G; Galeotti R; Giganti M
Minerva Med; 2003 Apr; 94(2):77-90. PubMed ID: 12858156
[TBL] [Abstract][Full Text] [Related]
9. The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumours: a prospective study.
Haubold-Reuter BG; Duewell S; Schilcher BR; Marincek B; von Schulthess GK
Eur J Nucl Med; 1993 Nov; 20(11):1063-9. PubMed ID: 8287874
[TBL] [Abstract][Full Text] [Related]
10. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
[TBL] [Abstract][Full Text] [Related]
11. Detection of malignant bone tumors: MR imaging vs scintigraphy.
Frank JA; Ling A; Patronas NJ; Carrasquillo JA; Horvath K; Hickey AM; Dwyer AJ
AJR Am J Roentgenol; 1990 Nov; 155(5):1043-8. PubMed ID: 2120933
[TBL] [Abstract][Full Text] [Related]
12. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer.
Engelhard K; Hollenbach HP; Wohlfart K; von Imhoff E; Fellner FA
Eur Radiol; 2004 Jan; 14(1):99-105. PubMed ID: 12845463
[TBL] [Abstract][Full Text] [Related]
13. Sub-super bone scan caused by bone marrow involvement of prostate cancer.
Seo Y; Shuke N; Yamamoto W; Usui K; Aburano T
Ann Nucl Med; 1999 Oct; 13(5):351-4. PubMed ID: 10582806
[TBL] [Abstract][Full Text] [Related]
14. Comparison of whole body MRI and radioisotope bone scintigram for skeletal metastases detection.
Chan Y; Chan K; Lam W; Metreweli C
Chin Med J (Engl); 1997 Jun; 110(6):485-9. PubMed ID: 9594253
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow scintigraphy in the diagnosis of bone metastasis in prostate cancer.
Fuse H; Nagakawa O; Seto H; Katayama T
Int Urol Nephrol; 1994; 26(1):53-61. PubMed ID: 8026923
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic imaging of bone metastases].
Scutellari PN; Addonisio G; Righi R; Giganti M
Radiol Med; 2000 Dec; 100(6):429-35. PubMed ID: 11307503
[TBL] [Abstract][Full Text] [Related]
17. [Radiologic diagnosis of bone metastases].
Hansmann HJ; Wunsch C; Schneider B; Brado M; Flesch M; Richter GM; Kauffmann GW
Orthopade; 1998 Apr; 27(4):224-30. PubMed ID: 9616881
[TBL] [Abstract][Full Text] [Related]
18. [Bone marrow scintigraphy using radiocolloids in bone metastases. Sensitivity, specificity, reliability and indications].
Fritz P; Adolph J; Bubeck B; Georgi P; zum Winkel K
Rofo; 1986 Jun; 144(6):689-95. PubMed ID: 3012705
[TBL] [Abstract][Full Text] [Related]
19. Radiological diagnosis of skeletal metastases.
Söderlund V
Eur Radiol; 1996; 6(5):587-95. PubMed ID: 8934120
[TBL] [Abstract][Full Text] [Related]
20. Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection--pilot study.
Earnest F; Ryu JH; Miller GM; Luetmer PH; Forstrom LA; Burnett OL; Rowland CM; Swensen SJ; Midthun DE
Radiology; 1999 Apr; 211(1):137-45. PubMed ID: 10189463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
